We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices

By LabMedica International staff writers
Posted on 17 Mar 2025
Print article
Image: A small, complex item printed using the 3D printing innovation (Photo courtesy of John O’Malley/Purdue University)
Image: A small, complex item printed using the 3D printing innovation (Photo courtesy of John O’Malley/Purdue University)

Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis, drug screenings, single-cell isolation, and point-of-care diagnostics. By controlling fluid flow and reaction conditions at the microliter or nanoliter scale, they facilitate advancements in biomedical research, enhance the accuracy and efficiency of diagnostic tests, and offer portable testing solutions across multiple fields. Traditionally, manufacturing microfluidic devices is expensive and labor-intensive, involving several steps and requiring high-end equipment and cleanroom environments. Now, a new innovation promises a quicker and more cost-effective method for producing these devices without the need for specialized facilities or expensive equipment.

Researchers at Purdue University (West Lafayette, IN, USA) are their patent-pending technique to fabricate affordable, multilevel microfluidic devices with dimensions as small as 10 microns deep and 100 microns wide. To put this into perspective, one micron is one-millionth of a meter, and 10 microns is one-tenth of the width of a human hair. The team's method leverages 3D printing, which constructs objects layer by layer, providing a faster and simpler alternative to the traditional fabrication process. While fused filament fabrication (FFF), a widely used 3D printing technique, has proven effective, it struggles to create smooth, narrow channels smaller than 500 microns. The team is improving upon traditional fabrication methods and 3D printing by using vat photopolymerization (VPP) which enables the direct fabrication of highly transparent microfluidics with a much higher resolution, allowing for channels as narrow as 100 microns. A key aspect of their technique involves using liquid crystal display (LCD) technology, which employs ultraviolet light to solidify the photopolymer and facilitate the fabrication process.

One critical application of microfluidics is single-cell analysis, where channel widths need to match the size of individual cells. The researchers successfully printed a microfluidic channel capable of forming a single line of cancer cells as they flowed through it, showcasing the technology’s potential for precise cell analysis. In addition to validating this concept by creating a single line of cancer cells, the team also fabricated intricate microfluidic networks that replicate the structure of capillaries. Furthermore, they have extended their approach to 3D print microfluidic devices with channels on curved surfaces. The results of this research were presented at the ASME International Mechanical Engineering Congress and Exposition, underscoring the potential of this innovative method to revolutionize microfluidic device fabrication across various industries.

“Our next development steps are bridging 3D printed microfluidic devices with conventional 2D microfluidics, which can combine the advantages of both 3D printing and 2D nanofabrication,” said Huachao Mao, assistant professor of engineering technology in the Purdue Polytechnic Institute, who is leading the research team.

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.